Cargando…

Use and feasibility of delayed prescribing for respiratory tract infections: A questionnaire survey

BACKGROUND: Delayed prescribing of antibiotics for respiratory tract infections (RTIs) lowers the amount of antibiotics consumed. Several national treatment guidelines on RTIs recommend the strategy. When advocating treatment innovations, the feasibility and credibility of the innovation must be tak...

Descripción completa

Detalles Bibliográficos
Autores principales: Høye, Sigurd, Frich, Jan C, Lindbæk, Morten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114766/
https://www.ncbi.nlm.nih.gov/pubmed/21592334
http://dx.doi.org/10.1186/1471-2296-12-34
_version_ 1782206108490792960
author Høye, Sigurd
Frich, Jan C
Lindbæk, Morten
author_facet Høye, Sigurd
Frich, Jan C
Lindbæk, Morten
author_sort Høye, Sigurd
collection PubMed
description BACKGROUND: Delayed prescribing of antibiotics for respiratory tract infections (RTIs) lowers the amount of antibiotics consumed. Several national treatment guidelines on RTIs recommend the strategy. When advocating treatment innovations, the feasibility and credibility of the innovation must be taken into account. The objective of this study was to explore GPs use and patients uptake of wait-and-see prescriptions for RTIs, and to investigate the feasibility of the strategy from GPs' and patients' perspectives. METHODS: Questionnaire survey among Norwegian GPs issuing and patients receiving a wait-and-see-prescription for RTIs. Patients reported symptoms, confidence and antibiotics consumption, GPs reported diagnoses, reason for issuing a wait-and-see-prescription and their opinion about the method. RESULTS: 304 response pairs from consultations with 49 GPs were received. The patient response rate was 80%. The most common diagnosis for the GPs to issue a wait-and-see prescription was sinusitis (33%) and otitis (21%). 46% of the patients reported to consume the antibiotics. When adjusted for other factors, the diagnosis did not predict antibiotic consumption, but both being 16 years or more (p = 0,006) and reporting to have a fever (p = 0,012) doubled the odds of antibiotic consumption, while feeling very ill more than quadrupled the odds (p = 0,002). In 210 cases (69%), the GP found delayed prescribing a very reasonable strategy, and 270 patients (89%) would prefer to receive a wait-and-see prescription in a similar situation in the future. The GPs found delayed prescribing very reasonable most frequently in cases of sinusitis (79%, p = 0,007) and least frequently in cases of lower RTIs (49%, p = 0,002). CONCLUSION: Most patients and GPs are satisfied with the delayed prescribing strategy. The patients' age, symptoms and malaise are more important than the diagnosis in predicting antibiotic consumption. The GP's view of the method as a reasonable approach depends on the patient's diagnosis. In our setting, delayed prescribing seems to be a feasible strategy, especially in cases of sinusitis and otitis. Educational efforts to promote delayed prescribing in similar settings should focus on these diagnoses.
format Online
Article
Text
id pubmed-3114766
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31147662011-06-15 Use and feasibility of delayed prescribing for respiratory tract infections: A questionnaire survey Høye, Sigurd Frich, Jan C Lindbæk, Morten BMC Fam Pract Research Article BACKGROUND: Delayed prescribing of antibiotics for respiratory tract infections (RTIs) lowers the amount of antibiotics consumed. Several national treatment guidelines on RTIs recommend the strategy. When advocating treatment innovations, the feasibility and credibility of the innovation must be taken into account. The objective of this study was to explore GPs use and patients uptake of wait-and-see prescriptions for RTIs, and to investigate the feasibility of the strategy from GPs' and patients' perspectives. METHODS: Questionnaire survey among Norwegian GPs issuing and patients receiving a wait-and-see-prescription for RTIs. Patients reported symptoms, confidence and antibiotics consumption, GPs reported diagnoses, reason for issuing a wait-and-see-prescription and their opinion about the method. RESULTS: 304 response pairs from consultations with 49 GPs were received. The patient response rate was 80%. The most common diagnosis for the GPs to issue a wait-and-see prescription was sinusitis (33%) and otitis (21%). 46% of the patients reported to consume the antibiotics. When adjusted for other factors, the diagnosis did not predict antibiotic consumption, but both being 16 years or more (p = 0,006) and reporting to have a fever (p = 0,012) doubled the odds of antibiotic consumption, while feeling very ill more than quadrupled the odds (p = 0,002). In 210 cases (69%), the GP found delayed prescribing a very reasonable strategy, and 270 patients (89%) would prefer to receive a wait-and-see prescription in a similar situation in the future. The GPs found delayed prescribing very reasonable most frequently in cases of sinusitis (79%, p = 0,007) and least frequently in cases of lower RTIs (49%, p = 0,002). CONCLUSION: Most patients and GPs are satisfied with the delayed prescribing strategy. The patients' age, symptoms and malaise are more important than the diagnosis in predicting antibiotic consumption. The GP's view of the method as a reasonable approach depends on the patient's diagnosis. In our setting, delayed prescribing seems to be a feasible strategy, especially in cases of sinusitis and otitis. Educational efforts to promote delayed prescribing in similar settings should focus on these diagnoses. BioMed Central 2011-05-18 /pmc/articles/PMC3114766/ /pubmed/21592334 http://dx.doi.org/10.1186/1471-2296-12-34 Text en Copyright ©2011 Høye et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Høye, Sigurd
Frich, Jan C
Lindbæk, Morten
Use and feasibility of delayed prescribing for respiratory tract infections: A questionnaire survey
title Use and feasibility of delayed prescribing for respiratory tract infections: A questionnaire survey
title_full Use and feasibility of delayed prescribing for respiratory tract infections: A questionnaire survey
title_fullStr Use and feasibility of delayed prescribing for respiratory tract infections: A questionnaire survey
title_full_unstemmed Use and feasibility of delayed prescribing for respiratory tract infections: A questionnaire survey
title_short Use and feasibility of delayed prescribing for respiratory tract infections: A questionnaire survey
title_sort use and feasibility of delayed prescribing for respiratory tract infections: a questionnaire survey
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114766/
https://www.ncbi.nlm.nih.gov/pubmed/21592334
http://dx.doi.org/10.1186/1471-2296-12-34
work_keys_str_mv AT høyesigurd useandfeasibilityofdelayedprescribingforrespiratorytractinfectionsaquestionnairesurvey
AT frichjanc useandfeasibilityofdelayedprescribingforrespiratorytractinfectionsaquestionnairesurvey
AT lindbækmorten useandfeasibilityofdelayedprescribingforrespiratorytractinfectionsaquestionnairesurvey